1. Scrip
  2. >>Leadership
  3. >>Executives On The Move

Appointments: Astellas, BIO, Hikma, Eton, Akili and Oxford BioDynamics

 
• By Lubna Ahmed

This week's roundup includes CEO appointments by Eton Pharmaceuticals, the Biotechnology Innovation Organization and Hikma, in addition to various other high-level appointments by Astellas, Akili Interactive Labs and Oxford BioDynamics.

Eton Pharmaceuticals Inc. has appointed Sean Brynjelsen CEO. Brynjelsen brings more than 20 years of experience in the industry to the company and previously worked at pharma companies, including Sagent Pharmaceuticals, Akorn Pharmaceuticals, Hospira and Baxter. Most recently, he was executive vice president of business development Sagent and before this, he was senior vice president, global business development for Akorn Inc.

The Biotechnology Innovation Organization (BIO) has named Alnylam Pharmaceuticals Inc.'s CEO, John Maraganore, chair of its board of directors. Julie Gerberding, Merck's executive vice president for strategic communications, global public policy & population health & chief patient officer, has been elected BIO's board secretary

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Executives On The Move

Executives On The Move: Five CEOs, Three CFOs And Two CMOs Among This Week’s Changes

Recent moves in the industry include changes at the top at Immunovant, Zymeworks and Cassava Sciences, among others, plus Zealand Pharma acquires chief scientific officer from Eli Lilly.

Executives On The Move: Ten CMOs And Three CEOs and CFOs Each Among This Week’s Changes

Recent moves in the industry include C-suite changes at Dyne Therapeutics, City Therapeutics and ProQR Therapeutics, plus Madrigal Pharmaceuticals acquires chief medical officer from Novartis.

Executives On The Move: Six CMOs, Five CEOs And Two CSOs Among This Week’s Changes

Recent moves in the industry include C-suite changes at Merck KGaA, Newleos Therapeutics and Artiva Biotherapeutics, plus Valo Therapeutics acquires chief executive officer from Johnson & Johnson.

Executives On The Move: Nine CEOs, Six CMOs And Three CFOs Among This Week’s Changes

Recent moves in the industry include changes at the top at Novo Nordisk and Takeda, plus Nxera Pharma nabs chief commercial officer from AstraZeneca.

More from Leadership